China (Mainland)
Diamondsupplier 
Eptifibatide CAS 188627-80-7 CAS NO.188627-80-7
- Min.Order: 10 Milligram
- Payment Terms: L/C,D/A,D/P,T/T
- Available Specifications:
- Product Details
Keywords
- Eptifibatide
- Eptifibatide Acetate
- 188627-80-7
Quick Details
- ProName: Eptifibatide CAS 188627-80-7
- CasNo: 188627-80-7
- Molecular Formula: C35h49n11o9s2
- Appearance: white powder
- Application: Eptifibatide
- DeliveryTime: 5 days
- PackAge: Vial or customized
- Port: Shanghai, Beijing, Shenzhen etc.
- ProductionCapacity: 100 Kilogram/Month
- Purity: 99%
- Storage: 2-8℃ sealed and away from light
- Transportation: Ocean and air shipping
- LimitNum: 10 Milligram
- Related Substances: Effective ingredients >99%
- Residue on Ignition: 0.1
- Heavy Metal: 0
- Valid Period: 3 years
Superiority
GMP Manafacturer
High Purity
Competitive Price
Short Delivery Time
Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Details
Eptifibatide CAS No.: 188627-80-7
Peptide Sequence:
Mpa-Har-Gly-Asp-Trp-Pro-Cys-NH2(Disulfide bridge: Mpa1-Cys6)
Eptifibatide is a platelet glycoprotein IIb/IIIa receptor reversible antagonist. It is used For acute coronary syndrome, coronary intervention before treatment and acute Q-wave myocardial infarction. It can relieve unstable angina symptoms and reduce the incidence of cardiovascular events.
| Product Name | Eptifibatide |
| CAS NO. | 188627-80-7 |
| Appearance | White Powder |
| Purity | 99% or customized |
| Application | Drug peptides |
| Usage | Eptifibatide is a platelet glycoprotein IIb/IIIa receptor reversible antagonist. |
Company Profile
Founded in 2011, Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of polypeptide pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation.
Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Jixianglong has 10 APIs production approvals, 16 invention patents achieved, including 5 compound patents.